GPT and cancer: To verify whether the ability of the miRNA to reduce TRF2 expression is not dependent on the cellular context, miR‐182‐3p was expressed in a panel of telomerase‐ (HeLa, HCT116, MDA‐MB‐231, MDA‐MB‐436) and ALT‐positive (U2‐OS, Saos‐2) cancer cells.